` 688193 (Shanghai Rendu Biotechnology Co Ltd) vs Shanghai Composite Comparison - Alpha Spread

S
688193
vs
S
Shanghai Composite

Over the past 12 months, Shanghai Rendu Biotechnology Co Ltd has outperformed Shanghai Composite, delivering a return of +31% compared to the Shanghai Composite's +22% growth.

Stocks Performance
688193 vs Shanghai Composite

Loading
688193
Shanghai Composite
Add Stock
www.alphaspread.com
No Stocks Selected

Compare the stock's returns with its benchmark index and competitors. Gain insights into its relative performance over time.

Select Stock to Compare

Performance Gap
688193 vs Shanghai Composite

Performance Gap Between 688193 and SSEC
HIDDEN
Show

Performance By Year
688193 vs Shanghai Composite

Loading
688193
Shanghai Composite
Add Stock
No Stocks Selected

Compare the stock's returns with its benchmark index and competitors. Gain insights into its relative performance over time.

Select Stock to Compare

Competitors Performance
Shanghai Rendu Biotechnology Co Ltd vs Peers

Shanghai Composite
688193
MTWO
XLO
Add Stock
No Stocks Selected

Compare the stock's returns with its benchmark index and competitors. Gain insights into its relative performance over time.

Select Stock to Compare

Shanghai Rendu Biotechnology Co Ltd
Glance View

Market Cap
2.1B CNY
Industry
Health Care

Shanghai Rendu Biotechnology Co., Ltd. develops molecular diagnostic tests. The company is headquartered in Shanghai, Shanghai and currently employs 528 full-time employees. The company went IPO on 2022-03-30. The firm utilizes ribonucleic acid (RNA) isothermal amplification technology to provides multiple series of diagnostic reagents, including respiration series, reproduction series, enterovirus series, blood-borne diseases series and other diagnostic reagents. The firm also designs and manufactures medical instruments. The firm mainly sells its products within domestic market.

Shanghai Rendu Biotechnology Co Ltd Intrinsic Value
HIDDEN
Show
Back to Top